Singular Genomics Systems (OMIC) Short Interest Ratio & Short Volume → Must-See: Elon’s New Invention is Absolutely Insane (From InvestorPlace) (Ad) Free OMIC Stock Alerts $0.39 +0.01 (+3.36%) (As of 12:23 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Singular Genomics Systems Short Interest DataCurrent Short Interest667,200 sharesPrevious Short Interest603,300 sharesChange Vs. Previous Month+10.59%Dollar Volume Sold Short$267,547.20Short Interest Ratio5.7 Days to CoverLast Record DateApril 30, 2024Outstanding Shares74,090,000 sharesFloat Size42,510,000 sharesShort Percent of Float1.57%Today's Trading Volume103,403 sharesAverage Trading Volume124,493 sharesToday's Volume Vs. Average83% Short Selling Singular Genomics Systems ? Sign up to receive the latest short interest report for Singular Genomics Systems and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartOMIC Short Interest Over TimeOMIC Days to Cover Over TimeOMIC Percentage of Float Shorted Over Time Ad True Market InsidersExposed: 10 CENT Crypto to Explode May 20th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 different coins that have returned over 100%... Today, he is now making the biggest crypto call of his ENTIRE career…Click For My #1 FREE Crypto for 2024 Singular Genomics Systems Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2024667,200 shares $267,547.20 +10.6%1.6%5.7 $0.40 4/15/2024603,300 shares $227,444.10 -17.6%1.4%5.3 $0.38 3/31/2024732,300 shares $376,548.66 -10.0%1.7%7.1 $0.51 3/15/2024813,500 shares $406,750.00 +7.3%1.9%6.5 $0.50 2/29/2024757,900 shares $432,003.00 -7.5%1.8%5.1 $0.57 2/15/2024819,000 shares $449,631.00 -5.9%2.0%4.9 $0.55 Get the Latest News and Ratings for OMIC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Singular Genomics Systems and its competitors with MarketBeat's FREE daily newsletter. 1/31/2024870,200 shares $439,451.00 -4.5%2.1%1.5 $0.51 1/15/2024911,200 shares $396,372.00 -17.2%2.2%1.6 $0.44 12/31/20231,100,000 shares $506,110.00 -5.2%2.6%1.9 $0.46 12/15/20231,160,000 shares $492,652.00 +3.6%2.8%2 $0.42 11/30/20231,120,000 shares $438,816.00 -27.3%2.7%1.9 $0.39 11/15/20231,540,000 shares $608,300.00 +40.0%3.7%2.6 $0.40 10/31/20231,100,000 shares $365,750.00 +8.9%2.7%2.3 $0.33 10/15/20231,010,000 shares $379,255.00 +3.4%2.5%4.2 $0.38 9/30/2023977,300 shares $372,351.30 +1.2%2.4%4.3 $0.38 9/15/2023965,800 shares $404,766.78 -3.3%2.4%3 $0.42 8/31/2023998,600 shares $469,242.14 +5.2%2.1%3.2 $0.47 8/15/2023949,400 shares $508,403.70 +1.7%2.0%3 $0.54 7/31/2023933,600 shares $740,251.44 +3.0%2.1%3.1 $0.79 7/15/2023906,200 shares $821,379.68 -0.1%2.0%3.2 $0.91 6/30/2023907,500 shares $753,225.00 -62.8%2.0%3.1 $0.83 6/15/20232,440,000 shares $2.08 million +10.9%5.5%8.3 $0.85 5/31/20232,200,000 shares $2.32 million +0.9%4.9%11.3 $1.06 5/15/20232,180,000 shares $1.95 million -0.9%4.9%12.1 $0.89 4/30/20232,200,000 shares $2.18 million +5.3%4.9%15 $0.99 4/15/20232,090,000 shares $2.15 million +3.0%4.7%14.8 $1.03 3/31/20232,030,000 shares $2.46 million +6.8%4.6%14.4 $1.21 3/15/20231,900,000 shares $2.43 million +8.6%4.3%14.1 $1.28 2/28/20231,750,000 shares $3.76 million -0.6%3.9%14.3 $2.15 2/15/20231,760,000 shares $4.24 million -10.2%4.0%15.3 $2.41 1/31/20231,960,000 shares $5.24 million -15.2%4.4%15.5 $2.68 1/15/20232,310,000 shares $4.87 million -3.4%5.3%17.1 $2.11 12/30/20222,390,000 shares $4.80 million -8.4%5.5%17 $2.01 12/15/20222,610,000 shares $5.87 million +1.6%6.4%15.6 $2.25 11/30/20222,570,000 shares $5.24 million -6.6%6.3%12.2 $2.04 11/15/20222,750,000 shares $6.57 million -2.8%7.7%12.1 $2.39 10/31/20222,830,000 shares $7.53 million -9.6%7.9%10.3 $2.66 10/15/20223,130,000 shares $7.26 million -2.8%8.8%11.4 $2.32 9/30/20223,220,000 shares $8.05 million +1.9%9.0%11.9 $2.50 9/15/20223,160,000 shares $10.59 million -3.4%8.9%10.2 $3.35What President Biden's new law means for investors (Ad)What's Got Musk, Bezos, and Gates So Excited? Billionaires are plowing millions of dollars into a new technology that early estimates say could generate more wealth than A.I. – and determine the future of companies like Microsoft. The problem? Most investors have no idea it's happening, or how to profit on it.This expert just went public with all the details, including which stocks to jump on immediately. 8/31/20223,270,000 shares $8.73 million +5.1%9.2%11.3 $2.67 8/15/20223,110,000 shares $13.40 million +12.3%8.4%8.8 $4.31 7/31/20222,770,000 shares $10.55 million -8.6%8.0%7.8 $3.81 7/15/20223,030,000 shares $12.54 million +3.8%8.7%7.8 $4.14 6/30/20222,920,000 shares $11.15 million +16.8%9.0%6.9 $3.82 6/15/20222,500,000 shares $7.53 million +0.4%7.7%5.9 $3.01 5/31/20222,490,000 shares $8.09 million -10.1%7.7%4.8 $3.25 5/15/20222,770,000 shares $9.14 million +15.4%8.6%4.9 $3.30 4/30/20222,400,000 shares $9.82 million +9.6%8.1%4.4 $4.09 4/15/20222,190,000 shares $10.77 million -20.7%7.2%4.1 $4.92 3/31/20222,760,000 shares $17.42 million +43.8%9.0%5.2 $6.31 3/15/20221,920,000 shares $12.48 million +8.5%6.3%3.7 $6.50 2/28/20221,770,000 shares $14.57 million +4.1%5.7%4.3 $8.23 2/15/20221,700,000 shares $13.21 million +7.6%5.5%4.6 $7.77 1/31/20221,580,000 shares $12.25 million +46.3%4.4%4.8 $7.75 1/15/20221,080,000 shares $8.38 million -6.1%3.0%3.7 $7.76 12/31/20211,150,000 shares $13.29 million +13.9%3.2%4.4 $11.56 12/15/20211,010,000 shares $11.89 million -21.1%2.8%4.1 $11.77 11/30/20211,280,000 shares $14.62 million +14.3%3.7%6.1 $11.42 11/15/20211,120,000 shares $16.68 million +17.4%3.2%5.9 $14.89 10/29/2021954,300 shares $13.22 million -2.5%2.8%6.2 $13.85 10/15/2021978,500 shares $13.72 million +12.5%2.8%7.3 $14.02 9/30/2021869,600 shares $9.73 million +27.0%2.5%6.1 $11.19 9/15/2021684,900 shares $9.53 million +3.0%2.0%4.6 $13.92 8/31/2021665,300 shares $10.99 million +13.5%1.9%5 $16.52 8/13/2021586,000 shares $8.92 million No Change1.7%2.3 $15.23 OMIC Short Interest - Frequently Asked Questions What is Singular Genomics Systems' current short interest? Short interest is the volume of Singular Genomics Systems shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 667,200 shares of OMIC short. 1.57% of Singular Genomics Systems' shares are currently sold short. Learn More on Singular Genomics Systems' current short interest. What is a good short interest ratio for Singular Genomics Systems? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. OMIC shares currently have a short interest ratio of 6.0. Learn More on Singular Genomics Systems's short interest ratio. What is a good short interest percentage for Singular Genomics Systems? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.57% of Singular Genomics Systems' floating shares are currently sold short. Is Singular Genomics Systems' short interest increasing or decreasing? Singular Genomics Systems saw a increase in short interest in April. As of April 30th, there was short interest totaling 667,200 shares, an increase of 10.6% from the previous total of 603,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Singular Genomics Systems' float size? Singular Genomics Systems currently has issued a total of 74,090,000 shares. Some of Singular Genomics Systems' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Singular Genomics Systems currently has a public float of 42,510,000 shares. How does Singular Genomics Systems' short interest compare to its competitors? 1.57% of Singular Genomics Systems' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Singular Genomics Systems: Rapid Micro Biosystems, Inc. (0.19%), Cara Therapeutics, Inc. (5.62%), Cue Health Inc. (0.46%), Accelerate Diagnostics, Inc. (2.51%), Talis Biomedical Co. (0.80%), Precipio, Inc. (0.28%), Prenetics Global Limited (1.44%), Bionano Genomics, Inc. (7.79%), Apollomics, Inc. (0.19%), Daré Bioscience, Inc. (0.29%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Singular Genomics Systems stock? Short selling OMIC is an investing strategy that aims to generate trading profit from Singular Genomics Systems as its price is falling. OMIC shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Singular Genomics Systems? A short squeeze for Singular Genomics Systems occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of OMIC, which in turn drives the price of the stock up even further. How often is Singular Genomics Systems' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including OMIC, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Rapid Micro Biosystems Short Interest Data Cara Therapeutics Short Interest Data Cue Health Short Interest Data Accelerate Diagnostics Short Interest Data Talis Biomedical Short Interest Data Precipio Short Interest Data Prenetics Global Short Interest Data Bionano Genomics Short Interest Data Apollomics Short Interest Data Daré Bioscience Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:OMIC) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority Gold"The Biggest Drug Ever" Is ComingBehind the MarketsMost important medical advance in 100 yearsThe Oxford ClubDoes this make you sick?Allegiance GoldThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingThis Apple-like Innovator is Revolutionizing HealthcareWall Street Star